Study links rosiglitazone with MI
Rosiglitazone, a drug commonly used to treat diabetes, is associated with an increased risk of myocardial infarction, a study has shown.
Sign in
In order to continue you need to be a registered user. If you would like to register to Nursing Times then click here.
